期刊文献+

RNA干扰对前列腺癌PC-3细胞血管内皮生长因子表达的研究 被引量:2

RNA Interference Inhibits VEGF Expression and Growth of PC-3 in Prostate Carcinoma
下载PDF
导出
摘要 目的:构建前列腺癌血管内皮生长因子(VEGF)RNA干扰(RNAi)真核表达载体,并研究RNAi对前列腺癌VEGF表达的影响。方法:合成VEGFRNAi片段,将RNAi片段定向克隆于RNAi表达载体,测序鉴定;RNAi表达载体转染人前列腺癌PC-3细胞,Western印迹法检测VEGFRNAi表达载体对VEGF蛋白表达的影响,MTT法检测转染VEGFRNAi表达载体对细胞生长的抑制作用。结果:成功构建VEGFRNAi真核表达载体;VEGFRNAi组VEGF蛋白的表达明显降低,显著低于空载体组和未转染的对照组;前列腺癌PC-3细胞24、48、72h的生长抑制率分别为23.5%、33.5%、40.8%。结论:VEGFRNAi可以抑制前列腺癌PC-3细胞蛋白的表达和抑制细胞生长,为前列腺癌的生物治疗提供一定的实验基础。 Objective: To construct a eukaryotic expression vector carrying human VEGF RNAi and to study the effect of RNA interference on VEGF expression in prostate carcinoma. Methods: VEGF RNAi was synthesized, inserted into the RNA interference eukaryotic expression vector, and confirmed by the reauh sequencing. The vector was transfected into prostate cancer PC-3, the VEGF expression detected by Western blot and the cell inhibiting rate determined by MTT. Results : The VEGF RNAi cukaryotic expression vector was successfully constructed. Compared with the empty vector group and the control group, the amount of VEGF protein expres- sion was obviously decreased in the VEGF RNAi group. The inhibiting rates were 23.5% , 33.5% and 40.8% at 24, 48 and 72 h re- spectively. Conclusion : VEGF RNAi can inhibit the protein expression and growth of PC-3, which provides an experimental base for the biological therapy of prostate cancer.
出处 《中华男科学杂志》 CAS CSCD 2006年第12期1095-1098,共4页 National Journal of Andrology
关键词 血管内皮生长因子 前列腺癌PC-3细胞 RNA干扰 VEGF prostate cancer RNA interference
  • 相关文献

参考文献9

  • 1Kollermann J,Helpap B.Expression of vascular endothelial growth factor (VEGF) and VEGF receptor Flk-1 in benign,premalignant,and malignant prostate tissue[J].Am J Clin Pathol,2001,116(1):115-121.
  • 2金铁雄,李晓刚,吴文元,朴东明,冯景琰,桑晶.环氧化酶2和血管内皮细胞生长因子在前列腺癌组织中的表达及意义[J].中华男科学杂志,2006,12(3):207-210. 被引量:8
  • 3Zhang L,Yang N,Mohamed-Hadley A,et al.Vector-based RNAi,a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer[J].Biochem Biophys Res Commun,2003,303(4):1169-1178.
  • 4West AF,O Donnell M,Charlton RG,et al.Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer[J].Br J Cancer,2001,85(4):576-583.
  • 5Latil A,Bieche I,Pesche S,et al.VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms[J].Int J Cancer,2000,89(2):167-171.
  • 6Strohmeyer D,Strauss F,Rossing C,et al.Expression of bFGF,VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma[J].Anticancer Res,2004,24 (3a):1797-1804.
  • 7Shariat SF,Anwuri VA,Lamb DJ,et al.Association of preoperative plasma levels of vascular endothelial growth factor and soluble vascular cell adhesion molecule-1 with lymph node status and biochemical progression after radical prostatectomy[J].J Clin Oncol,2004,22 (9):1655-1663.
  • 8Izquierdo M.Short interfering RNAs as a tool for cancer gene therapy[J].Cancer Gene Ther,2005,12(3):217-227.
  • 9高丽芳,徐德启,邵月婷,赵丹,赵雪俭.RNA干扰技术沉默STAT3对人前列腺癌细胞生长的抑制作用[J].中华男科学杂志,2005,11(1):29-33. 被引量:17

二级参考文献19

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1368
  • 2严春寅,黄玉华,温端改,侯建全,浦金贤,丁翔.缺氧诱导因子-1α与前列腺癌生物学行为的关系[J].江苏医药,2005,31(7):489-491. 被引量:6
  • 3Weiss JM, Nath A, Major EO, et al. HIV-1 Tat induces monocyte chemoattractant protein-l-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes[ J]. J Immunol, 1999,163 ( 5 ) :2953-2959.
  • 4Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis[J]. Oncogene, 2000, 19(21) :2474-2488.
  • 5Grandis JR, Drenning SD, Zeng Q, et al. Constitutive activation of STAT3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo [ J ]. Proc Natl Acad Sci USA, 2000, 97 (8):4227 -4232.
  • 6Schuringa JJ, Wierenga AT, Knfijer W, et al. Constitutive STAT3,Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6 [ J ].Blood, 2000, 95(12) :3765-3770.
  • 7Badache A, Hynes NE. Interleukin 6 inhibits proliferation and,in cooperation with an epidermal growth factor receptor autocrine loop, increases migration of T47D breast cancer cells [ J ]. CancerRes, 2001,61 ( 1 ) :383-391.
  • 8Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention[J]. Clin Cancer Res, 2002, 8(4) :945-954.
  • 9Bromberg JF, Horvath CM, Besser D, et al. STAT3 activation is required for cellular transformation by v-src [ J ]. Mol Cell Biol,1998, 18(5) :2553-2558.
  • 10Leong PL, Andrews GA, Johnson DE, et al. Targeted inhibition of STAT3 with a decoy oligonucleotide abrogates head and neck cancer cell growth[J]. Proc Natl Acad Sci USA, 2003,100(7) :4138-4143.

共引文献23

同被引文献54

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部